Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Boonen

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
Annals of the Rheumatic Diseases|January 18, 2006
Safety and patient satisfaction of infliximab administration in an extramural setting supervised by a rheumatology specialist nurseY van Eijk, A Boonen, G Schulpen, et al.
Arthritis Care & Research|January 4, 2012
Physical activity and body composition in patients with ankylosing spondylitisG Plasqui, A Boonen, P Geusens, et al.
Arthritis Care & Research|January 22, 2015
Health and Utilities in Patients With Gout Under the Care of a RheumatologistB Spaetgens, A Tran-Duy, J M A Wijnands, et al.
The Journal of Rheumatology|January 26, 1999
The responsiveness of generic quality of life instruments in rheumatic diseases. A systematic review of randomized controlled trialsZ Ortiz, B Shea, M Garcia Dieguez, et al.
Clinical Rheumatology|May 17, 2005
Healthcare consumption and direct costs of rheumatoid arthritis in BelgiumR Westhovens, A Boonen, L Verbruggen, et al.
International Journal of Colorectal Disease|January 1, 1989
Risk factors which determine the long term outcome of Neodymium-YAG laser palliation of colorectal carcinomaE Van Cutsem, A Boonen, K Geboes, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 3, 2020
Interventions to improve adherence to anti-osteoporosis medications: an updated systematic reviewD Cornelissen, S de Kunder, L Si, et al.
Rheumatology (Oxford, England)|August 11, 2006
Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoidsT P van Staa, P Geusens, B Zhang, et al.
Clinical and Experimental Rheumatology|May 29, 2009
Classification models for disease: the effect of associations between markers on calculating the risk for disease by likelihood ratio productsR Wittoek, F De Keyser, A Boonen, et al.
The Journal of Rheumatology|March 25, 1999
Smallest detectable difference in radiological progressionM Lassere, M Boers, D van der Heijde, et al.
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
Annals of the Rheumatic Diseases|January 18, 2006
Safety and patient satisfaction of infliximab administration in an extramural setting supervised by a rheumatology specialist nurseY van Eijk, A Boonen, G Schulpen, et al.
Arthritis Care & Research|January 4, 2012
Physical activity and body composition in patients with ankylosing spondylitisG Plasqui, A Boonen, P Geusens, et al.
Arthritis Care & Research|January 22, 2015
Health and Utilities in Patients With Gout Under the Care of a RheumatologistB Spaetgens, A Tran-Duy, J M A Wijnands, et al.
The Journal of Rheumatology|January 26, 1999
The responsiveness of generic quality of life instruments in rheumatic diseases. A systematic review of randomized controlled trialsZ Ortiz, B Shea, M Garcia Dieguez, et al.
Clinical Rheumatology|May 17, 2005
Healthcare consumption and direct costs of rheumatoid arthritis in BelgiumR Westhovens, A Boonen, L Verbruggen, et al.
International Journal of Colorectal Disease|January 1, 1989
Risk factors which determine the long term outcome of Neodymium-YAG laser palliation of colorectal carcinomaE Van Cutsem, A Boonen, K Geboes, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 3, 2020
Interventions to improve adherence to anti-osteoporosis medications: an updated systematic reviewD Cornelissen, S de Kunder, L Si, et al.
Rheumatology (Oxford, England)|August 11, 2006
Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoidsT P van Staa, P Geusens, B Zhang, et al.
Clinical and Experimental Rheumatology|May 29, 2009
Classification models for disease: the effect of associations between markers on calculating the risk for disease by likelihood ratio productsR Wittoek, F De Keyser, A Boonen, et al.
The Journal of Rheumatology|March 25, 1999
Smallest detectable difference in radiological progressionM Lassere, M Boers, D van der Heijde, et al.
Pageof 11